%PDF-1.4
%
55 0 obj
<>
endobj
57 0 obj
<>stream
2020-03-06T11:18:56-05:00
QuarkXPress(R) 13.0
2024-03-28T22:26:41-07:00
2024-03-28T22:26:41-07:00
QuarkXPress(R) 13.0
application/pdf
Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events
%%DocumentProcessColors: Cyan Magenta Yellow Black
%%EndComments
uuid:76f504dc-1dd2-11b2-0a00-cd09277d8900
uuid:76f50512-1dd2-11b2-0a00-d30000000000
endstream
endobj
10 0 obj
<>]>>
endobj
48 0 obj
<>
endobj
49 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
50 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
51 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
52 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
53 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
54 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
84 0 obj
[89 0 R]
endobj
85 0 obj
<>stream
HW[o~ϯ06
vlX-Ҽ5E
8}$3sN/r5onpؿ+XOoR(/owjcV:4|ZbugEx\wƲѱ9V$XMG "5}4Hp' C=鉽oȤE|grXyWNȎ>lĘ}tXOH>,m$QViA*dT֞KyU~w